Full Text
Cost-Minimization analysis of Infliximab versus Adalimumab in the treatment of Crohn’s disease and Ulcerative Colitis

Abstract

Authors

E. De Paula V.d. Blumer Y.C. Trevizam E.W. Asano

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×